| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| humant tetanusantitoxin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
|
| Product containing human tetanus immunoglobulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
1 |
| tetanusimmunglobulin 250 IE injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
|
| tetanusimmunglobulin 2500 IE infusionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
|
| tetanusimmunglobulin 250 IE injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
|
| Administration of human tetanus immune globulin (procedure) |
Direct substance |
False |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
3 |
| Administration of human tetanus immune globulin (procedure) |
Direct substance |
True |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
1 |
| Intramuscular injection of human tetanus immunoglobulin |
Direct substance |
True |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
1 |
| Product containing only human tetanus immunoglobulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
1 |
| Product containing human tetanus immunoglobulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
1 |
| Product containing only human tetanus immunoglobulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
1 |
| Product containing precisely human tetanus immunoglobulin 250 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
1 |
| Product containing precisely human tetanus immunoglobulin 250 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
1 |
| Product containing precisely human tetanus immunoglobulin 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
1 |
| Product containing precisely human tetanus immunoglobulin 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Human tetanus immunoglobulin |
Inferred relationship |
Some |
1 |
FHIR